Evidence map›Paper›PMID 34502134›Full record

ArticleInternational journal of molecular sciences2021

SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.

Guoshuai Cai, Mulong Du, Yohan Bossé, Helmut Albrecht, Fei Qin, Xizhi Luo, Xiao Michelle Androulakis, Chao Cheng, Mitzi Nagarkatti, Prakash Nagarkatti and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. The Role of Glycans in Human Immunity-A Sweet Code.Molecules (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. The role of dendritic cells in COVID-19 infection.Emerging microbes & infections · 2023
    Review
  10. Review
  11. Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19.International journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Guoshuai CaiDepartment of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
Mulong DuDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2733-6490
Yohan BosséDepartment of Molecular Medicine, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Laval University, Quebec City, QC G1V 4G5, Canada.ORCID 0000-0002-3067-3711
Helmut AlbrechtPrisma Health Medical Group, Department of Internal Medicine, University of South Carolina, Columbia, SC 29208, USA.
Fei QinDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.ORCID 0000-0003-3678-2879
Xizhi LuoDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
Xiao Michelle AndroulakisNeurology, Columbia VA Health System, Columbia, SC 29209, USA.ORCID 0000-0002-1833-3474
Chao ChengDepartment of Medicine, Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.
Mitzi NagarkattiDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-5977-5615
Prakash NagarkattiDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0003-2663-0759
David C ChristianiDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-0301-0242
Michael L WhitfieldDepartment of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Christopher I AmosDepartment of Medicine, Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-8540-7023
Feifei XiaoDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
University of South Carolina · USBaylor College of Medicine · USHarvard University · USDartmouth College · USInstitut universitaire de cardiologie et de pneumologie de Québec · CAPrisma Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current spreading coronavirus SARS-CoV-2 is highly infectious and pathogenic. In this study, we screened the gene expression of three host receptors (ACE2, DC-SIGN and L-SIGN) of SARS coronaviruses and dendritic cells (DCs) status in bulk and single cell transcriptomic datasets of upper airway, lung or blood of COVID-19 patients and healthy controls. In COVID-19 patients, DC-SIGN gene expression was interestingly decreased in lung DCs but increased in blood DCs. Within DCs, conventional DCs (cDCs) were depleted while plasmacytoid DCs (pDCs) were augmented in the lungs of mild COVID-19. In severe cases, we identified augmented types of immature DCs (CD22

Indexed as

Angiotensin-Converting Enzyme 2Cell Adhesion MoleculesCOVID-19Datasets as TopicDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsGene Expression RegulationGenome-Wide Association StudyHost-Pathogen InteractionsHumansImmunity, InnateLectins, C-TypeLungMendelian Randomization AnalysisNasopharynxReceptors, Cell SurfaceACE2 protein, humanAngiotensin-Converting Enzyme 2Cell Adhesion MoleculesCLEC4M protein, humanDC-Specific ICAM-3 Grabbing NonintegrinLectins, C-TypeReceptors, Cell SurfaceACE2COVID-19DC-SIGNdendritic cellsL-SIGN

Identifiers

PMID34502134
PMCPMC8431536
OpenAlexW3196229969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.